Antibodies against glutamic acid decarboxylase (GAD), the rate-limiting enzyme in the synthesis of the inhibitory neurotransmitter g-aminobutyric acid (GABA), are associated with various neurological disorders, including stiff-person syndrome, cerebellar ataxia, epilepsy, and limbic encephalitis. The gene discussed is GAD1; the disease is stiff-person syndrome.